Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis.

Détails

Ressource 1Télécharger: LSA-2021-01256.pdf (3866.36 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_EE3F03CA49EA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis.
Périodique
Life science alliance
Auteur⸱e⸱s
Katakam S., Anand S., Martin P., Riggi N., Stamenkovic I.
ISSN
2575-1077 (Electronic)
ISSN-L
2575-1077
Statut éditorial
Publié
Date de publication
03/2022
Peer-reviewed
Oui
Volume
5
Numéro
3
Pages
e202101256
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Malignant tumors commonly display necrosis, which invariably triggers an inflammatory response that supports tumor growth. However, the effect on tumor cells of necrotic debris, or damage-associated molecular patterns (DAMPs) released by dying cells is unknown. Here, we addressed the effect of DAMPs on primary Ewing sarcoma (EwS) cells and cell lines grown in 3D (spheroids) and 2D culture. We show that DAMPs promote the growth of EwS spheroids but not 2D cultures and that the underlying mechanism implicates an increase in cholesterol load in spheroids. In contrast, stimulation of the nucleic acid sensor signaling platform STING by its ligand cyclic GMP-AMP decreases the tumor cell cholesterol load and reduces their tumor initiating ability. Overexpression of STING or stimulation with cyclic GMP-AMP opposes the growth stimulatory effect of DAMPs and synergizes with the cholesterol synthesis inhibitor simvastatin to inhibit tumor growth. Our observations show that modulation of cholesterol homeostasis is a major effect of necrotic cell debris and STING and suggest that combining STING agonists with statins may help control tumor growth.
Mots-clé
Alarmins/metabolism, Apoptosis, Biomarkers, Cell Line, Tumor, Cholesterol/metabolism, Disease Management, Disease Susceptibility, Gene Expression Regulation, Neoplastic, Homeostasis, Humans, Lipid Metabolism, Membrane Proteins/metabolism, Necrosis/metabolism, Neoplasms/etiology, Neoplasms/metabolism, Neoplasms/pathology, Neoplasms/therapy, Spheroids, Cellular, Tumor Cells, Cultured
Pubmed
Open Access
Oui
Création de la notice
10/01/2022 10:13
Dernière modification de la notice
18/10/2023 7:24
Données d'usage